Monday, December 23, 2024
HomeTags25mg

25mg

Relmada Therapeutics Announces Publication of REL-1017 Phase 2 Study Results in The American Journal of Psychiatry

Relmada Therapeutics, Inc., a late-stage biotechnology company addressing diseases of the central nervous system (CNS), announced the publication of Phase 2 data from the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics